Dynamic straining combined with fibrin gel cell seeding improves strength of tissue-engineered small-diameter vascular grafts.
Vascular tissue engineering represents a promising approach for the development of living small-diameter vascular grafts that can be used for replacement therapy. The culture of strong human tissue-engineered (TE) vascular grafts has required long culture times, up to several months, whether or not combined with gene therapy. This article describes the culture of strong, genetically unmodified, human TE vascular grafts in 4 weeks Small-diameter vascular grafts were engineered using a fast-degrading polyglycolic acid scaffold coated with poly-4-hydroxybutyrate combined with fibrin gel and seeded with myofibroblasts isolated from discarded saphenous veins from patients undergoing coronary bypass surgery. The TE grafts were subjected to dynamic strain conditions. After 28 d of in vitro culture, the grafts demonstrated burst pressures of 903 +/- 123 mmHg. Comparison with native vessels (intact human left internal mammary arteries (LIMAs) and saphenous veins) showed no significant differences in the amount of DNA, whereas the TE vessels contained approximately 50% of the native collagen content. In the physiological pressure range, up to 300 mmHg, the mechanical properties of the TE vessels were comparable to the LIMA. In this study, we showed that dynamic conditioning combined with fibrin gel cell seeding enhances the mechanical properties of small-diameter TE grafts. These grafts might provide a promising alternative to currently used vascular replacements.
Stekelenburg
Maria
M
Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. m.stekelenburg@tue.nl
Rutten
Marcel C M
MC
Snoeckx
Luc H E H
LH
Baaijens
Frank P T
FP
D000328:Adult; D000368:Aged; D001672:Biocompatible Materials; D001696:Biomechanical Phenomena; D001705:Bioprosthesis; D001807:Blood Vessel Prosthesis; D005337:Fibrin; D005782:Gels; D006801:Humans; D008323:Mammary Arteries / Q000033:anatomy & histology / Q000502:physiology; D008875:Middle Aged; D011091:Polyesters; D011100:Polyglycolic Acid; D012501:Saphenous Vein / Q000033:anatomy & histology / Q000502:physiology; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds
D001672:Biocompatible Materials; D005782:Gels; D011091:Polyesters; C107955:poly(4-hydroxybutanoate); D011100:Polyglycolic Acid; D005337:Fibrin